Bristol-Myers Squibb Company
Aminotriazolopyridines as kinase inhibitors

Abstract:

Compounds having formula (I) (IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein: (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX). ##STR00001## ##STR00002##